Orbimed Advisors LLC Protagonist Therapeutics, Inc Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$10.78 - $25.38 $3.24 Million - $7.64 Million
301,000 New
301,000 $6.92 Million
Q2 2020

Aug 14, 2020
SELL
$6.19 - $18.84 $414,166 - $1.26 Million
-66,909 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$5.4 - $9.22 $671,220 - $1.15 Million
-124,300 Reduced 65.01%
66,909 $472,000
Q4 2019

Feb 14, 2020
BUY
$4.69 - $13.45 $896,770 - $2.57 Million
191,209 New
191,209 $1.35 Million

Others Institutions Holding PTGX

# of Institutions
247
Shares Held
56.4M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email